SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001395064-21-000004
Filing Date
2021-01-25
Accepted
2021-01-25 06:07:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga-012521.htm SC 13G/A 67746
2 EX-99.1 exhibit991-012521.htm EX-99.1 2810
3 EX-99.2 exhibit992-012521.htm EX-99.2 7588
  Complete submission text file 0001395064-21-000004.txt   79745
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Subject) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90547 | Film No.: 21547772
SIC: 2836 Biological Products, (No Diagnostic Substances)